Vertex Pharmaceuticals
UnverifiedManufacturerBoston, MAFounded 1989Nasdaq: VRTX
Overview
Vertex Pharmaceuticals is a Boston-based company that reports one operating segment, pharmaceuticals. Its marketed products are KALYDECO, ORKAMBI, SYMDEKO, TRIKAFTA and ALYFTREK in cystic fibrosis, CASGEVY (developed with CRISPR) and JOURNAVX, and it is developing povetacicept in IgA nephropathy, acquired with Alpine Immune Sciences in 2024. Its US field teams are organized by business unit.
Hiring snapshot
Hiring by specialty
Open roles
Newest first, from Vertex Pharmaceuticals’s careers page.
- Pain Territory Business Manager, Grand Rapids, MI/ Fort Wayne, INGrand Rapids, Michigan +15d ago$140k–$160k
- Pain Territory Business Manager, Morgantown, WVMorgantown, West Virginia5d ago$140k–$160k
- Kidney Territory Account Manager (Greenville/Columbia, SC)South Carolina8d ago$134k–$200k
- Center Account Manager, Northwest (Cystic Fibrosis)California10d ago$122k–$184k
- Center Account Manager, Cystic Fibrosis (Midwest - Michigan and Illinois)Boston, Massachusetts10d ago$122k–$184k
- Gene Therapy Account Management, Associate Director - Southeast territory which includes FL, GA and ALBoston, Massachusetts10d ago$160k–$240k
Divisions
Division information is pending company verification.Once Vertex Pharmaceuticals claims its page, you will see each division, who it calls on and how it pays.
Claim your pageMore from Vertex Pharmaceuticals
These sections fill in when Vertex Pharmaceuticals claims and verifies its page.